PHARMACYTE BIOTECH, INC. Stock Issued During Period, Shares, Restricted Stock Award, Gross
PHARMACYTE BIOTECH, INC. (PMCB) reported Stock Issued During Period, Shares, Restricted Stock Award, Gross of 875.00 thousand shares for the 0-month period ending 2025-12-11, per its 10-K filed 2026-07-29.
Financial Statements › Shareholders' Equity › Shares Granted or Issued, Share-Based Payment Arrangement
us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross · last filed 2026-07-29
- 2025-12-11: Stock Issued During Period, Shares, Restricted Stock Award, Gross 0 month 875.00K shares.
| Period end | Stock Issued During Period, Shares, Restricted Stock Award, Gross 0 month |
|---|---|
| 2025-12-11 | 875.00K shares 10-K · filed 2026-07-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |